11 Apr NexPlasmaGen is a TieQuest 2026 finalist for the Grand Final
Montreal / April 11, 2026 – NexPlasmaGen is immensely proud to announce that it is a finalist in the Medical Device category of the prestigious TieQuest 2026 competition and is making it to the Grand Final!
TiEQuest 2026 (TiEQuest 2026 | TiE – Global Entrepreneurship Organization) is a 10-week accelerator and pitch competition designed to help Canadian startups go further and faster. It helps founders fine-tune product-market fit, accelerate growth, and prepare globally. Through TiE’s powerful international network, startups gain direct exposure to leading investors in Canada, Silicon Valley, Boston, New York, and India. At TiEQuest, entrepreneurs don’t just compete, they build. Along the way, they have access to capital, mentorship, and markets, while connecting with leaders who have grown businesses globally.
NexPlasmaGen has completed Phase 1 of this competition, which includes workshops and mentorship, Phase 2 on elevator pitch, and Phase 3 on the creation of a business plan. Now, she is heading to Phase 4, the Grand Finale of the 2026 TiEQuest Summit, to compete in front of investors for a cash prize and investment. NexPlasmaGen would like to thank the organizers of the TiEQuest 2026 sincerely. This program really helped NexPlasmaGen refine its business plan and pitch deck among other business aspects!
ABOUT NEXPLASMAGEN
NexPlasmaGen converges the emerging field of cold plasma biotechnology towards personalized cancer treatment. We develop high-precision cold plasma systems that destroy cancer cells while sparing the healthy tissue. The first application of NexPlasmaGen is the treatment of breast cancer, followed by skin and lung cancer. Its patented cold plasma medical device has the potential to reduce the rate of cancer recurrence as well as side effects and toxicity of the standard of care for the benefit of patients.
Contact:
Dr. Valérie Léveillé, ing., M.Sc.A., CEO/Founder
Tel. : 1-514-229-9458
Email : valerie.leveille@nexplasmagen.com
Website : https://nexplasmagen.com/
No Comments